2 active not recruiting, 1 recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 2, Recruiting 1 |
Follow FutureChem: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 3 Study of [177Lu]Ludotadipep for Metastatic Castration-Resistant Prostate Cancer [177-Lu]Ludotadipep, Best supportive care/standard of care (BSC/SOC) alone - Prostate Cancer, mCRPC | Phase 3 | Recruiting | FutureChem | 114 | 2026-01-26 | 2026-10-01 |
| [18F]Florastamin PET/CT Imaging Examination in Patients With Suspected Recurrent or Metastatic Prostate Cancer [F-18]Florastamin - High Risk Prostate Carcinoma | Phase 3 | Active not recruiting | FutureChem | 138 | 2023-05-08 | 2025-03-12 |
| Evaluate the Clinical Usefulness of [F-18]Florastamin PET/CT Imaging Diagnosis Compared to MRI Diagnosis [F-18]Florastamin - High Risk Prostate Carcinoma | Phase 3 | Active not recruiting | FutureChem | 398 | 2021-04-28 | 2025-03-12 |
Prostatic Neoplasms (3) · Genital Diseases (1) · Genital Neoplasms, Male (1) · Male Urogenital Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Prostatic Diseases (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1)
Single Person (1)
South Korea (3)
Jae Young Joung, Ph.D (1) · Ji Youl Lee (1) · Ji Youl Lee, Ph.D (1)